COMMUNIQUÉS West-GlobeNewswire

Orphazyme endorses patient advocacy consensus guidelines, highlights importance of collaboration with patient communities

15/10/2018 - 09:08

Orphazyme A/S Investor News No. 12/2018 Company Registration No. 32266355 Orphazyme supports consensus guidelines to direct interactions with rare disease patient advocacy organizations Company extends heartfelt [...]

Chairman of the Board will not seek re-election

15/10/2018 - 08:22

Company announcement no.15/2018 For further information please contact: Martin Riise, Head of Investor Relations, Tel: +45 5339 2250 Camilla Lercke, Head of Media Relations, Tel: +45 5339 2384 About Chr. Hansen Chr. [...]

Annual Report 2017/18

15/10/2018 - 08:00

Company announcement no.14/2018 For further information, please contact: Head of IR Martin Riise Tel.: +45 5339 2250 dkmari@chr-hansen.com IR Officer Annika Stern Tel.: +45 2399 2382 dkaste@chr-hansen.com FORWARD- [...]

Rule 2.9 Announcement

15/10/2018 - 08:00

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 15 October 2018 [...]

ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 22nd tranche of investment today

15/10/2018 - 07:18

Amsterdam, The Netherlands - 15 October 2018 Esperite N.V. (Euronext: ESP, "Esperite" or "the Group") announces that today a 22 nd Tranche of EUR 400,000 is issued as a private placement of 40 convertible notes (the " [...]

Santhera Receives Positive Opinion for Orphan Drug Designation in the EU for POL6014 in Cystic Fibrosis

15/10/2018 - 07:01

Pratteln, Switzerland, October 15, 2018 - Santhera Pharmaceuticals (SIX: SANN) announces that the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA) has issued a positive opinion on [...]

Probiodrug AG: Loss announcement according to §92 paragraph 1 of the German Stock Corporation Act

15/10/2018 - 07:01

Probiodrug AG: Loss announcement according to §92 paragraph 1 of the German Stock Corporation Act HALLE (SAALE), Germany, 15 October 2018 - The management board of Probiodrug AG ("Probiodrug", Euronext: PBD), a clinical [...]

Telix and ANMI Expand PSMA Imaging Partnership

15/10/2018 - 00:00

MELBOURNE, Australia and LIÈGE, Belgium, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the development of [...]

Telix and Cyclotek Enter into Manufacturing Partnership for Kidney Cancer Imaging

15/10/2018 - 00:00

MELBOURNE, Australia, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the development of diagnostic and [...]

Free Health Visits, Available Through Teladoc Health, to Residents Impacted by Hurricane Michael

12/10/2018 - 22:05

Residents and Those Displaced Can Call 855-764-1727 to Access Treatment for Non-Emergency Illnesses PURCHASE, NY, Oct. 12, 2018 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, is [...]

Terra Tech Corp. Announces Plans to Expand its Cannabis Dispensary Footprint with Purchase of Las Vegas Property

12/10/2018 - 22:05

IRVINE, Calif., Oct. 12, 2018 (GLOBE NEWSWIRE) -- Terra Tech Corp. (OTCQX: TRTC), (“Terra Tech” or the “Company”) a vertically integrated cannabis-focused agriculture company, today announced it has purchased a retail [...]

Trevena to Present Phase 3, Open-Label Safety Study of Oliceridine at the American Society of Anesthesiologists Annual Meeting

12/10/2018 - 22:01

CHESTERBROOK, Pa., Oct. 12, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ: TRVN) today announced a poster presentation at ANESTHESIOLOGY® 2018, the national conference for the American Society of Anesthesiologists (ASA [...]

A Letter from Emblem’s President & CEO

12/10/2018 - 19:51

TORONTO, Oct. 12, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC, OTCQX: EMMBF ) (" Emblem " or the " Company ") delivers strategic vision to shareholders: With adult-use legalization only days away, I am incredibly [...]

Michael DePerro, MD, Offers Minimally Invasive Gynecomastia Surgery Technique

12/10/2018 - 19:29

This unique approach helps reduce scarring that typically results from the procedure. COLUMBUS, Ohio, Oct. 12, 2018 (GLOBE NEWSWIRE) -- Dr. Michael DePerro , double board-certified plastic surgeon and head of DePerro [...]

NovuHealth Named No. 5 on Minneapolis/St. Paul Business Journal's Fast 50 List for Two Years Running

12/10/2018 - 19:00

Company Is Top Healthcare Firm on List of the 50 Fastest-Growing Private Companies in the Twin Cities, with 230% Growth from 2015-2017 MINNEAPOLIS, Oct. 12, 2018 (GLOBE NEWSWIRE) -- NovuHealth , the healthcare industry’ [...]

Innovation Pharmaceuticals Brilacidin as a Novel Inhibitor of Phosphodiesterase 4 (PDE4) Supports its Potential to Treat Autoimmune and Inflammatory Diseases; Company Invited to Present at Upcoming Crohn’s & Colitis Foundation Conference

12/10/2018 - 18:00

BEVERLY, Mass., Oct. 12, 2018 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals, (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to provide this update on Brilacidin as a novel [...]

RAMSAY GENERALE DE SANTE : supplement to the offer document in respect of the public offer to the shareholders of Capio

12/10/2018 - 17:47

PRESS RELEASE THIS PRESS RELEASE MAY NOT, DIRECTLY OR INDIRECTLY, BE DISTRIBUTED OR PUBLISHED IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, OR SOUTH AFRIC A. THE OFFER IS NOT BEING MADE TO (AND [...]

RAMSAY GENERALE DE SANTE : complément au document d'offre relatif à l'offre publique d'achat faite aux actionnaires de Capio

12/10/2018 - 17:47

COMMUNIQUE DE PRESSE LE PRESENT COMMUNIQUE DE PRESSE NE PEUT ETRE, DIRECTEMENT OU INDIRECTEMENT, DISTRIBUE OU PUBLIE EN AUSTRALIE, CANADA, HONG KONG, JAPON, NOUVELLE ZELANDE, OU AFRIQUE DU SUD. L'OFFRE N'EST PAS FAITE [...]

Trident Brands Inc. Entering US Hemp CBD Market with Brain Armor® R3 Supplement

12/10/2018 - 17:34

Brookfield, WI, Oct. 12, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Trident Brands Inc. (OTCQB: TDNT), a biotech and nutraceutical company, announces that Brain Armor® will launch a line of products that include CBD [...]